| Directing human induced pluripotent stem cells into a neurosensory lineage for auditory neuron replacement N Gunewardene, NV Bergen, D Crombie, K Needham, M Dottori, ... BioResearch Open Access 3 (4), 162-175, 2014 | 55 | 2014 |
| The convergence of cochlear implantation with induced pluripotent stem cell therapy N Gunewardene, M Dottori, BA Nayagam Stem Cell Reviews and Reports 8, 741-754, 2012 | 41 | 2012 |
| Electrophysiological properties of neurosensory progenitors derived from human embryonic stem cells K Needham, T Hyakumura, N Gunewardene, M Dottori, BA Nayagam Stem Cell Research 12 (1), 241-249, 2014 | 30 | 2014 |
| Applications of Lgr5-positive cochlear progenitors (LCPs) to the study of hair cell differentiation DR Lenz, N Gunewardene, DE Abdul-Aziz, Q Wang, TM Gibson, ... Frontiers in Cell and Developmental Biology 7, 14, 2019 | 29 | 2019 |
| Hybrid optogenetic and electrical stimulation for greater spatial resolution and temporal fidelity of cochlear activation AC Thompson, AK Wise, WL Hart, K Needham, JB Fallon, ... Journal of Neural Engineering 17 (5), 056046, 2020 | 27 | 2020 |
| Innervation of cochlear hair cells by human induced pluripotent stem cell-derived neurons in vitro N Gunewardene, D Crombie, M Dottori, BA Nayagam Stem cells international 2016, 2016 | 26 | 2016 |
| Adenosine amine congener ameliorates cisplatin-induced hearing loss N Gunewardene, CX Guo, ACY Wong, P Thorne, S Vlajkovic | 15 | 2013 |
| Viral-mediated transduction of auditory neurons with opsins for optical and hybrid activation RT Richardson, AC Thompson, AK Wise, EA Ajay, N Gunewardene, ... Scientific Reports 11 (1), 11229, 2021 | 13 | 2021 |
| Pharmacokinetics and biodistribution of supraparticle-delivered neurotrophin 3 in the guinea pig cochlea N Gunewardene, P Lam, Y Ma, F Caruso, S Wagstaff, RT Richardson, ... Journal of Controlled Release 342, 295-307, 2022 | 12 | 2022 |
| Emerging therapies for human hearing loss E Ajay, N Gunewardene, R Richardson Expert opinion on biological therapy 22 (6), 689-705, 2022 | 9 | 2022 |
| A radiolabeled drug tracing method to study neurotrophin-3 retention and distribution in the cochlea after nano-based local delivery P Lam, N Gunewardene, Y Ma, F Caruso, T Nguyen, B Flynn, AK Wise, ... MethodsX 7, 101078, 2020 | 5 | 2020 |
| Developing the supraparticle technology for round window-mediated drug administration into the cochlea N Gunewardene, Y Ma, P Lam, S Wagstaff, C Cortez-Jugo, Y Hu, ... Journal of Controlled Release 361, 621-635, 2023 | 4 | 2023 |
| Gene Therapy Approaches for Cochlear Repair RT Richardson, N Gunewardene Elsevier, 2020 | 1 | 2020 |
| Inhibition of lysine demethylase 1 (lsd1) induces differentiation of hair cells A Edge, N Gunewardene | | 2020 |
| Enabling Temporal Control of Gene Expression in the Inner Ear after AAVAnc80 Mediated Delivery DR Lenz, N Gunewardene, R Churchill, R Richardson, A Wise, R Ng MOLECULAR THERAPY 28 (4), 255-256, 2020 | | 2020 |
| The Potential of Induced Pluripotent Stem Cells for Spiral Ganglion Neuron Replacement N Gunewardene University of Melbourne, Department of Otolaryngology, 2014 | | 2014 |
| The Therapeutic Potential of Adenosine Amine Congener (ADAC) in Ameliorating Cisplatin Induced Ototoxicity N Gunewardene University of Auckland, 2010 | | 2010 |
